Clinical Trial Update: Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Hycamtin (topotecan) plus carboplatin against established regimens for relapsed ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Hycamtin (Topotecan)

Snippet

Sponsor: North Eastern German Society of Gynaecological Oncology | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED